Listed

Xtant Medical Holdings, Inc.: Form 10-K for the period ended Dec 31, 2016

Filed with the SEC on Mar 29, 2017 and accepted by EDGAR at Mar 29, 2017, 12:49 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2016-01-01 to 2016-12-31$90.0mus-gaap:SalesRevenueNet
Cost of revenue12 months2016-01-01 to 2016-12-31$27.7mus-gaap:CostOfGoodsAndServicesSold
Gross profit12 months2016-01-01 to 2016-12-31$62.3mus-gaap:GrossProfit
Research and development12 months2016-01-01 to 2016-12-31$3.4mus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2016-01-01 to 2016-12-31−$7.5mus-gaap:OperatingIncomeLoss
Interest expense12 months2016-01-01 to 2016-12-31$12.3mus-gaap:InterestExpense
Income tax12 months2016-01-01 to 2016-12-31$50.4kus-gaap:IncomeTaxExpenseBenefit
Net income12 months2016-01-01 to 2016-12-31−$19.5mus-gaap:NetIncomeLoss
Diluted EPS12 months2016-01-01 to 2016-12-31−$1.54us-gaap:EarningsPerShareDiluted
Basic EPS12 months2016-01-01 to 2016-12-31−$1.54us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2016-01-01 to 2016-12-3112,671,685 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Capital expenditure12 months2016-01-01 to 2016-12-31$5.8mus-gaap:PaymentsToAcquireProductiveAssets
Cash and equivalentsAt period end2016-12-31$2.6mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2016-12-31$49.0mus-gaap:AssetsCurrent
Total assetsAt period end2016-12-31$144.1mus-gaap:Assets
Current liabilitiesAt period end2016-12-31$31.1mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2016-12-31$151.2mus-gaap:Liabilities
Long-term debtAt period end2016-12-31$119.2mus-gaap:LongTermDebt
Shareholders' equityAt period end2016-12-31−$7.1mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-17-017200. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.